Cellular markers of eryptosis are altered in type 2 diabetes

Clin Chem Lab Med. 2018 Jun 27;56(7):e177-e180. doi: 10.1515/cclm-2017-1058.

Daniela S Kempe-Teufel^{1

2}, Rosi Bissinger³, Syed M Qadri^{4

5}, Robert Wagner^{1

2

6}, Andreas Peter^{1

2

6}, Florian Lang^{3

7

8}

¹ Department of Internal Medicine IV, Divisions of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.
² Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (IDM), Tübingen, Germany.
³ Department of Internal Medicine III, Eberhard-Karls University of Tübingen, Tübingen, Germany.
⁴ Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
⁵ Centre for Innovation, Canadian Blood Services, Hamilton, ON, Canada.
⁶ German Center for Diabetes Research (DZD), Neuherberg, Germany.
⁷ Physiologisches Institut der Universität Tübingen, Gmelinstr. 5, 72076 Tübingen, Germany.
⁸ Department of Molecular Medicine II, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.

No abstract available

Keywords: anemia; ceramide; diabetes; eryptosis; erythrocytes.

Publication types